AGI-134
AGI-134 is a synthetic alpha-Gal glycolipid that activates CD8+ T cell-mediated immunity, leading to targeted tumor cell lysis and phagocytosis. This mechanism supports its research application in studying immunotherapeutic strategies against cancer in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
1821461-84-0
Smiles
O ([C@@H]1[C@@H] (CO) O[C@@H] (OCCCNC (CCCCC (NCCOP (OC[C@H] (OC (CCCCCCC/C=C\CCCCCCCC) =O) COC (CCCCCCC/C=C\CCCCCCCC) =O) (=O) O) =O) =O) [C@H] (NC (C) =O) [C@H]1O) [C@H]2[C@H] (O) [C@@H] (O[C@H]3O[C@H] (CO) [C@H] (O) [C@H] (O) [C@H]3O) [C@@H] (O) [C@@H] (CO) O2
Molecular Formula
C70H126N3O26P
Molecular Weight
1456.73
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MA4796-.1 100 µL
Anti-Pulmonary Surfactant Associated Protein D Rabbit Monoclonal Antibody
Sign In for Pricing
View Details